176 related articles for article (PubMed ID: 2201659)
1. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U
Int J Clin Pharmacol Res; 1990; 10(1-2):75-9. PubMed ID: 2201659
[TBL] [Abstract][Full Text] [Related]
2. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
Passeri M; Iannuccelli M; Ciotti G; Bonati PA; Nolfe G; Cucinotta D
Int J Clin Pharmacol Res; 1988; 8(5):367-76. PubMed ID: 3229874
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological changes in demented patients treated with acetyl-L-carnitine.
Sinforiani E; Iannuccelli M; Mauri M; Costa A; Merlo P; Bono G; Nappi G
Int J Clin Pharmacol Res; 1990; 10(1-2):69-74. PubMed ID: 2387665
[TBL] [Abstract][Full Text] [Related]
4. [Effects of L-acetylcarnitine on mental deterioration in the aged: initial results].
Cipolli C; Chiari G
Clin Ter; 1990 Mar; 132(6 Suppl):479-510. PubMed ID: 2140973
[TBL] [Abstract][Full Text] [Related]
5. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
Herrmann WM; Dietrich B; Hiersemenzel R
Int J Clin Pharmacol Res; 1990; 10(1-2):81-4. PubMed ID: 2201660
[TBL] [Abstract][Full Text] [Related]
6. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain.
Bonavita E
Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):511-6. PubMed ID: 3781687
[TBL] [Abstract][Full Text] [Related]
7. Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholism.
Tempesta E; Troncon R; Janiri L; Colusso L; Riscica P; Saraceni G; Gesmundo E; Calvani M; Benedetti N; Pola P
Int J Clin Pharmacol Res; 1990; 10(1-2):101-7. PubMed ID: 2201652
[TBL] [Abstract][Full Text] [Related]
8. L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia.
Goety CG; Tanner CM; Cohen JA; Thelen JA; Carroll VS; Klawans HL; Fariello RG
Mov Disord; 1990; 5(3):263-5. PubMed ID: 2143808
[No Abstract] [Full Text] [Related]
9. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia.
Lenzi A; Sgrò P; Salacone P; Paoli D; Gilio B; Lombardo F; Santulli M; Agarwal A; Gandini L
Fertil Steril; 2004 Jun; 81(6):1578-84. PubMed ID: 15193480
[TBL] [Abstract][Full Text] [Related]
10. Effects of acetyl-L-carnitine on reaction times in patients with cerebrovascular insufficiency.
Arrigo A; Casale R; Buonocore M; Ciano C
Int J Clin Pharmacol Res; 1990; 10(1-2):133-7. PubMed ID: 2387660
[TBL] [Abstract][Full Text] [Related]
11. [Methodology of a clinical controlled study of L-acetylcarnitine].
Neri M; Cortelloni C; De Vreese L
Clin Ter; 1990 Mar; 132(6 Suppl):457-68. PubMed ID: 2140970
[TBL] [Abstract][Full Text] [Related]
12. [The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results].
Acierno G
Clin Ter; 1983 Apr; 105(2):135-45. PubMed ID: 6345054
[No Abstract] [Full Text] [Related]
13. [A controlled randomized trial of the use of combined L-carnitine and acetyl-L-carnitine treatment in men with oligoasthenozoospermia].
Li Z; Chen GW; Shang XJ; Bai WJ; Han YF; Chen B; Teng XM; Meng FH; Zhang B; Chen DN; Liu JH; Zheng XM; Cao XR; Liu Y; Zhu XB; Wang YX
Zhonghua Nan Ke Xue; 2005 Oct; 11(10):761-4. PubMed ID: 16281510
[TBL] [Abstract][Full Text] [Related]
14. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia.
Balercia G; Regoli F; Armeni T; Koverech A; Mantero F; Boscaro M
Fertil Steril; 2005 Sep; 84(3):662-71. PubMed ID: 16169400
[TBL] [Abstract][Full Text] [Related]
15. L-acetylcarnitine treatment of mental decline in the elderly.
Salvioli G; Neri M
Drugs Exp Clin Res; 1994; 20(4):169-76. PubMed ID: 7813389
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic facial paralysis: new therapeutic prospects with acetyl-L-carnitine.
Mezzina C; De Grandis D; Calvani M; Marchionni A; Pomes A
Int J Clin Pharmacol Res; 1992; 12(5-6):299-304. PubMed ID: 1301409
[TBL] [Abstract][Full Text] [Related]
17. L-acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo.
Tempesta E; Casella L; Pirrongelli C; Janiri L; Calvani M; Ancona L
Drugs Exp Clin Res; 1987; 13(7):417-23. PubMed ID: 3308388
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression.
Garzya G; Corallo D; Fiore A; Lecciso G; Petrelli G; Zotti C
Drugs Exp Clin Res; 1990; 16(2):101-6. PubMed ID: 2205455
[TBL] [Abstract][Full Text] [Related]
19. Effect of acetyl-L-carnitine on geriatric patients suffering from dysthymic disorders.
Bella R; Biondi R; Raffaele R; Pennisi G
Int J Clin Pharmacol Res; 1990; 10(6):355-60. PubMed ID: 2099360
[TBL] [Abstract][Full Text] [Related]
20. [A controlled clinical study on the efficacy of L-acetylcarnitine in the treatment of mild-to-moderate mental deterioration in the aged. Conclusions].
Genazzani E
Clin Ter; 1990 Mar; 132(6 Suppl):511-2. PubMed ID: 2140974
[No Abstract] [Full Text] [Related]
[Next] [New Search]
